EP1753423A4 - Benzoureas having anti-diabetic activity - Google Patents
Benzoureas having anti-diabetic activityInfo
- Publication number
- EP1753423A4 EP1753423A4 EP05812065A EP05812065A EP1753423A4 EP 1753423 A4 EP1753423 A4 EP 1753423A4 EP 05812065 A EP05812065 A EP 05812065A EP 05812065 A EP05812065 A EP 05812065A EP 1753423 A4 EP1753423 A4 EP 1753423A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- benzoureas
- diabetic activity
- diabetic
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57514404P | 2004-05-28 | 2004-05-28 | |
PCT/US2005/018721 WO2006022954A2 (en) | 2004-05-28 | 2005-05-26 | Benzoureas having anti-diabetic activity |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1753423A2 EP1753423A2 (en) | 2007-02-21 |
EP1753423A4 true EP1753423A4 (en) | 2009-10-21 |
Family
ID=35967997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05812065A Withdrawn EP1753423A4 (en) | 2004-05-28 | 2005-05-26 | Benzoureas having anti-diabetic activity |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1753423A4 (en) |
JP (1) | JP2008501027A (en) |
CN (1) | CN101076334A (en) |
AU (1) | AU2005278099A1 (en) |
CA (1) | CA2565803A1 (en) |
WO (1) | WO2006022954A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006014685A1 (en) * | 2006-03-28 | 2007-10-04 | Sanofi-Aventis | New bicyclic imidazolone derivatives useful as endothelial lipase inhibitors, e.g. for treating disorders of fat metabolism or glucose utilization |
ES2390620T3 (en) * | 2008-03-10 | 2012-11-14 | Nestec S.A. | Medium chain dicarboxylic acids and their derivatives and metabolic disorders |
WO2014046697A1 (en) * | 2012-09-21 | 2014-03-27 | Reoxcyn Discoveries Group, Inc. | Cell for electrolyzing a liquid |
CN117279923A (en) * | 2021-04-27 | 2023-12-22 | 南京明德新药研发有限公司 | Derivative of six-membered heteroaromatic urea ring and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624935A (en) * | 1994-04-11 | 1997-04-29 | Sankyo Company, Limited | Heterocyclic compounds having anti-diabetic activity and their use |
WO2004019869A2 (en) * | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653478B2 (en) * | 2000-10-27 | 2003-11-25 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulators |
-
2005
- 2005-05-26 WO PCT/US2005/018721 patent/WO2006022954A2/en not_active Application Discontinuation
- 2005-05-26 AU AU2005278099A patent/AU2005278099A1/en not_active Abandoned
- 2005-05-26 CN CNA2005800171945A patent/CN101076334A/en active Pending
- 2005-05-26 CA CA002565803A patent/CA2565803A1/en not_active Abandoned
- 2005-05-26 EP EP05812065A patent/EP1753423A4/en not_active Withdrawn
- 2005-05-26 JP JP2007515386A patent/JP2008501027A/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624935A (en) * | 1994-04-11 | 1997-04-29 | Sankyo Company, Limited | Heterocyclic compounds having anti-diabetic activity and their use |
WO2004019869A2 (en) * | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
Non-Patent Citations (1)
Title |
---|
BRAJ B. LOHRAY ET AL: "Novel euglycemic and hypolipidemic agents. 1", JOURNAL OF MEDICINAL CHEMISTRY, vol. 41, no. 10, 1998, pages 1619 - 1630, XP002149048, ISSN: 0022-2623 * |
Also Published As
Publication number | Publication date |
---|---|
JP2008501027A (en) | 2008-01-17 |
AU2005278099A1 (en) | 2006-03-02 |
CN101076334A (en) | 2007-11-21 |
WO2006022954A3 (en) | 2006-10-12 |
WO2006022954A2 (en) | 2006-03-02 |
CA2565803A1 (en) | 2006-03-02 |
EP1753423A2 (en) | 2007-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2006003810A0 (en) | 4-Phenylamino-quinazolin-6-yl-amides | |
DE602005007474D1 (en) | Substituierte morpholin- und thiomorpholinderivate | |
DE502005007040D1 (en) | Laryngoskop | |
DE602004014986D1 (en) | Terminal-box | |
DE502005007456D1 (en) | Nanoemulsionen | |
DE602005008719D1 (en) | Notinformationsschild | |
DE502005003298D1 (en) | Ls | |
IL181297A0 (en) | Benzamide compounds | |
DE602005010119D1 (en) | Roboterhandvorrichtung | |
DE502005009795D1 (en) | Modulares gelenkprothesensystem | |
DE602005003029D1 (en) | Polyaminoamidmonoepoxyaddukte | |
AU303644S (en) | Sofa | |
DE502004004685D1 (en) | Giessmaschine | |
DE502005010653D1 (en) | Eiten | |
EP1753423A4 (en) | Benzoureas having anti-diabetic activity | |
DE502005006813D1 (en) | Common-rail-injektor | |
DE502004004917D1 (en) | Multiaxialkomplex | |
GB0424565D0 (en) | Activity aid | |
GB0427340D0 (en) | Bedding | |
DE502005004945D1 (en) | Auto-splice-system | |
ZA200701801B (en) | Benzamide compounds | |
GB0406449D0 (en) | Headboards | |
GB0521886D0 (en) | Glycosyltrasferase activity | |
AU3324P (en) | Walpurple Hardenbergia violacea | |
AU2909P (en) | DT23 Dianella tasmanica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR LV MK YU |
|
17P | Request for examination filed |
Effective date: 20070412 |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20070412 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20070412 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090923 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 3/10 20060101ALI20090917BHEP Ipc: A61K 31/428 20060101ALI20090917BHEP Ipc: A61K 31/42 20060101ALI20090917BHEP Ipc: C07D 417/14 20060101ALI20090917BHEP Ipc: C07D 413/10 20060101ALI20090917BHEP Ipc: C07D 413/14 20060101AFI20090917BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MERCK SHARP & DOHME CORP. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091223 |